Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gentz

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cancer Research|August 1, 1997
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRGY E Shi, J Ni, G Xiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 9, 2001
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cellsZ Han, J Ni, P Smits, et al.
Cell|June 14, 1996
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complexM Muzio, A M Chinnaiyan, F C Kischkel, et al.
The Journal of Biological Chemistry|April 18, 1997
Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatinsJ Ni, M Abrahamson, M Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 1999
VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivoY Zhai, J Ni, G W Jiang, et al.
The Journal of Biological Chemistry|May 30, 1997
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activationB S Kwon, K B Tan, J Ni, et al.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
The Journal of Clinical Investigation|September 17, 1998
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transferY Zhai, R Guo, T L Hsu, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cancer Research|August 1, 1997
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRGY E Shi, J Ni, G Xiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 9, 2001
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cellsZ Han, J Ni, P Smits, et al.
Cell|June 14, 1996
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complexM Muzio, A M Chinnaiyan, F C Kischkel, et al.
The Journal of Biological Chemistry|April 18, 1997
Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatinsJ Ni, M Abrahamson, M Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 1999
VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivoY Zhai, J Ni, G W Jiang, et al.
The Journal of Biological Chemistry|May 30, 1997
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activationB S Kwon, K B Tan, J Ni, et al.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
The Journal of Clinical Investigation|September 17, 1998
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transferY Zhai, R Guo, T L Hsu, et al.
Pageof 8